Pi-Cardia Successfully Performs Mitral Valve Splitting With ShortCut(TM) | BioSpace
CustomersExpand
Pi-Cardia Receives FDA IDE Approval for Pivotal Study with ShortCut(TM) Device
CustomersExpand
Innovative non-surgical solutions for aortic valve stenosis
Customers
Pi-Cardia Successfully Treats First Patients with ShortCut™ Device
Heart valve co Pi-Cardia teams with China's Venus Medtech
Partners
Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex™ Aortic Valve Technology
Investment
Pi-Cardia Appoints Prof. Jacques Séguin As Chairman " Cardiology2.0
Pi-Cardia First-in-Human Study Shows Significant Improvement in Aortic Valve Function Following Treatment With its Novel Non-Implant Based Leaflex™ Catheter
CustomersPartners
Pi-Cardia Initiates First-in-Human Study With Novel Non-Implant Based Treatment of Aortic Stenosis
Expand
Pi-Cardia Completes $10M Financing
Investment
Clal Biotech to invest in heart valve co Pi R Squared
Investment